Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 512 of 1,261
  1. US 10226454

    Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

    Theravance Biopharma R&D IP, LLC · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  2. US 10227630

    Antimicrobial agents from microbial genomes

    The Regents of the University of California · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  3. US 10227565

    Generating hepatocytes

    The Regents of the University of California · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  4. US 10227610

    Methods and compositions for enhancing nuclease-mediated gene disruption

    Sangamo Therapeutics, Inc. · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  5. US 10227323

    Glucosylceramide synthase inhibitors for the treatment of diseases

    BIOMARIN PHARMACEUTICAL INC. · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  6. US 10227395

    Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  7. US 10227302

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  8. US 10227352

    Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity

    Northwestern University · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  9. US 10226535

    Auristatin compounds and conjugates thereof

    Mersana Therapeutics, Inc. · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  10. US 10226526

    Vaccines for human papilloma virus and methods for using the same

    Inovio Pharmaceuticals, Inc. · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  11. US 10226523

    Clostridium difficile vaccine and methods of use

    The Board of Regents of the University of Oklahoma · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  12. US 10226521

    Genetically modified Yersinia as vaccines against Yersinia species

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  13. US 10227290

    Glycosphingolipids for use in modulating immune responses

    The Regents of the University of California · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  14. US 10226534

    Semi-solid delivery systems

    Regents of the University of Minnesota · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  15. US 10226488

    Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof

    UNIVERSITY OF CONNECTICUT · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  16. US 10226485

    Multipotent adult stem cells and methods for isolation

    Regents of the University of Minnesota · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  17. US 10226512

    Method for treating heart failure with preserved ejection fraction by administering human relaxin-2

    Relaxera Pharmazeutische Gesellschaft mbH & Co. KG · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  18. US 10226516

    Process, tube and device for the preparation of wound healant composition

    RegenLab USA LLC · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  19. US 10226468

    Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

    Asana BioSciences, LLC · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  20. US 10226452

    Benzoxazolone derivatives as acid ceramidase inhibitors, and their use as medicaments

    The Regents of the University of California · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  21. US 10226420

    Methods of eye treatment using therapeutic compositions containing dipyridamole

    O.D. Ocular Discovery Ltd. · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  22. US 10226518

    Ubiquitinylated proteins

    Providence Health & Science—Oregon · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  23. DK 2928905

    FREMGANGSMÅDE TIL OPRENSNING AF TERAPEUTISKE PROTEINER

    CSL BEHRING GMBH [DE] · Granted Mar 11, 2019 · Expires Mar 6, 2039

    granted
  24. WO 2019043176

    INHIBITEUR DE L'HISTONE-DÉSACÉTYLASE EN ASSOCIATION AVEC UN AGENT ANTIMÉTABOLITE POUR LA CANCÉROTHÉRAPIE

    4SC AG [DE] · Granted Mar 7, 2019 · Expires Mar 2, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.